Unity Biotechnology, Inc.
UBX
$0.977
-$0.0067-0.68%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.50M | -25.99M | -21.89M | -30.19M | -40.37M |
| Total Depreciation and Amortization | 818.00K | 867.00K | 895.00K | 987.00K | 1.08M |
| Total Amortization of Deferred Charges | -- | -- | 0.00 | 148.00K | 391.00K |
| Total Other Non-Cash Items | 2.09M | 867.00K | -3.49M | 2.90M | 8.74M |
| Change in Net Operating Assets | 2.55M | 3.39M | 1.95M | 1.70M | -791.00K |
| Cash from Operations | -22.04M | -20.87M | -22.54M | -24.46M | -30.96M |
| Capital Expenditure | -- | -- | 0.00 | -11.00K | -11.00K |
| Sale of Property, Plant, and Equipment | 7.00K | 26.00K | 140.00K | 134.00K | 134.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.52M | 8.54M | 18.96M | 26.72M | 31.90M |
| Cash from Investing | 22.53M | 8.57M | 19.10M | 26.84M | 32.03M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | -16.77M | -20.00M |
| Issuance of Common Stock | 77.00K | 77.00K | 4.46M | 4.46M | 5.00M |
| Repurchase of Common Stock | -- | -- | -- | -48.00K | -48.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | -1.56M | -1.56M |
| Cash from Financing | 77.00K | 77.00K | 4.46M | -13.92M | -16.61M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 569.00K | -12.22M | 1.02M | -11.53M | -15.54M |